January 16, 2025 - 22:21

SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve Replacement (TAVR). This innovative procedure represents a significant advancement in cardiac care, allowing for a minimally invasive method to replace a patient's aortic valve. The transcarotid approach offers several benefits, including reduced recovery times and lower risks of complications compared to traditional surgical methods.
The team at SGMC Health, comprised of skilled cardiologists and surgeons, worked collaboratively to ensure the procedure was performed with the highest standards of care. This milestone not only highlights the hospital's commitment to adopting cutting-edge medical technologies but also reflects its dedication to improving patient outcomes.
The successful execution of the first transcarotid TAVR procedure positions SGMC Health as a leader in cardiac interventions within the region. As the medical community continues to embrace innovative techniques, patients can look forward to more effective and less invasive treatment options for heart conditions.
July 2, 2026 - 04:03
VA health secretary quits less than a year into tenureJohn Bartrum, the official who oversaw the Veterans Health Administration`s troubled rollout of a new electronic health records system, has resigned from his post less than a year after taking the...
July 1, 2026 - 08:37
Anglia Ruskin mental health nursing course under reviewThe Nursing and Midwifery Council has called for an `extraordinary review` of the mental health nursing course at Anglia Ruskin University. The regulatory body`s decision comes amid concerns over...
June 30, 2026 - 22:44
Politics: High Cost Of Healthcare And The Political FalloutAmericans are feeling the squeeze of rising healthcare expenses like never before. For the first time in five years, fewer than half of U.S. adults say they can consistently afford medical care,...
June 30, 2026 - 15:13
Top GLP-1 prescription indications include sleep apnea, depression and kidney disease, study findsA new analysis of insurance claims data reveals that prescriptions for GLP-1 medications are increasingly being approved for conditions far beyond their original use for diabetes and weight loss....